Archive for December, 2008

EPIX Screamer on 25-Times Volume (EPIX)

Epix Pharmaceuticals Inc (NASDAQ: EPIX) did something crazy today, even for a micro-cap, even for a quiet market, and even for FDA news.  Its Vasovist imaging agent for magnetic resonance angiography was approved for use in detecting narrow or blocked blood vessels carrying oxygenated blood from the heart.  Vasovist is already marketed in 34 countries [...]

Price/Volume Spike: Baidu.com (BIDU)

Baidu.com Inc. (NASDAQ: BIDU) is surging after the stock rating was raised to the CONVICTION BUY LIST at Goldman Sachs this morning with a 6-month price target of $145.00. FULL RESEARCH SUMMARY Shares at 9:33 AM EST are up 9.9% at $129.91 after closing at $118.09 yesterday.  We have already seen more than 400,000 shares [...]

Down Volume Spike: Apple (AAPL)

Apple Inc. (NASDAQ: AAPL) is getting hit this morning in pre-market trading.  The iPod, iPhone, and iMac maker saw its shares cut to Neutral from Buy with a new price target of $115.00 at Goldman Sachs. Full summary details of the downgrade. Shares are down less than 2% pre-market at $96.40 with about 230,000 shares [...]

Wednesday Trader Radar (GENZ, ALXA, GNW, YHOO, ERTS, ARNA, AXP)

Genzyme Corp. (NASDAQ: GENZ) won a recommendation from the FDA advisory committee unanimously recommending approval of Genzyme’s Synvisc-one for osteoarthritis in the knee. Shares are indicated up almost 3% at $65.00. Just keep in mind that its market cap is now $17 billion. Alexza Pharmaceuticals Inc. (NASDAQ: ALXA) announced that its AZ-004, an inhalation product [...]

Volume Spike: Research in Motion (RIMM)

Research in Motion Ltd. (NASDAQ: RIMM) is trading down about 6% pre-market to around $35.30 on over 150,000 shares as of 7:37 AM EST.  It seems that woes of Palm Inc. (PALM) after its own warning are not isolated. The maker of the Blackberry smartphones lowered its revenue projections down to a range of $2.75 [...]

Downward Volume Surge: Xenoport (XNPT)

Xenoport (NASDAQ: XNPT) said that results from a Phase 2 clinical trial of XP19986 as a treatment for the symptoms of gastroesophageal reflux disease were generally well tolerated.  Unfortunately, the study results of the primary analysis comparing XP19986 to the placebo did not reach statistical significance. Shares are getting crushed on this.  Shares are at [...]

Volume Spike: Solarfun Power (SOLF)

Solarfun Power Holdings (NASDAQ: SOLF) is being hit pretty hard pre-market on disappointing earnings.  Shares are doiwn almost 14% at $4.05 with 23 minutes until the market opens.  We have seen over 50,000 shares trade hands, and it trades more than 2 million shares per day.  Its 52-week trading range is $2.67 to $40.19. JON [...]

Volume Tanker: Tessera (TSRA)

Tessera Technologies Inc. (NASDAQ: TSRA) is still way down pre-market after it dropped a bomb in the after-hours session.  Shares had slid 9.5% yesterday to $16.62 at the close, and shares were down by 42% at $9.73 last night.  It is actually worse this morning with shares down at $9.33 with 30 minutes to the [...]

Monster After-Hours Volume Spike: Tessera (TSRA)

Tessera Technologies Inc. (NASDAQ: TSRA) dropped a bomb in the afdter-hours session.  The company said that the ITC issued an initial determination in its Wireless ITC action.  The Administrative Law Judge overseeing the International Trade Commission action brought by Tessera against certain wireless manufacturers (Qualcomm-QCOM was one) issued an Initial Determination finding Tessera’s asserted patents [...]